InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: None

Sunday, 09/25/2016 7:35:44 AM

Sunday, September 25, 2016 7:35:44 AM

Post# of 345789
Dysf binds phosphatidylserine

Published : Sept 19 2016

Dysferlin-mediated phosphatidylserine sorting engages macrophages in sarcolemma repair

http://www.nature.com/ncomms/2016/160919/ncomms12875/full/ncomms12875.html

PS: check out the supplementary movies from link above....this naturally tells me that targeting flipped ps for injuries / muscle repair / post hockey games etc will be a natural fit



"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News